Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) saw a significant decrease in short interest in July. As of July 15th, there was short interest totaling 6,349 shares, a decrease of 55.6% from the June 30th total of 14,284 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 45,861 shares, the days-to-cover ratio is currently 0.1 days.
Nihon Kohden Price Performance
NHNKY stock traded up $0.16 during trading on Tuesday, reaching $9.86. The company had a trading volume of 8,882 shares, compared to its average volume of 28,423. Nihon Kohden has a 52 week low of $8.12 and a 52 week high of $14.21. The business has a 50 day moving average of $9.03 and a 200 day moving average of $9.86. The company has a market cap of $1.66 billion, a P/E ratio of 16.71 and a beta of 0.39.
Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%.The business had revenue of $453.10 million for the quarter, compared to analysts’ expectations of $414.40 million. Research analysts expect that Nihon Kohden will post 0.6 earnings per share for the current year.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on Nihon Kohden
Nihon Kohden Company Profile
Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.
The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.
Featured Articles
- Five stocks we like better than Nihon Kohden
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.
